BRF2 and ovarian carcinoma: Figure 2A demonstrates that BDP1 mRNA expression was observed to be significantly decreased in ovarian cancer, p = 0.01; however, the TFIIIB subunits BRF1, BRF2, and TBP mRNA expression was not significantly altered in ovarian cancer, Figure 2B‐D.